Why is Venmax Drugs falling/rising?

As of 05-Aug, Venmax Drugs & Pharmaceuticals Ltd is experiencing a price increase, currently at Rs 26.99, reflecting a rise of Rs 1.04 or 4.01%. The stock has shown strong performance today, outperforming its sector by 4.96% and achieving a consecutive gain over the last two days with a total return of 7.32%. It opened with a significant gain of 4.82% and reached an intraday high of Rs 27.22. Additionally, the stock has demonstrated a positive trend over the past month with a return of 10.80%, although it has declined by 1.85% over the past week. Notably, there has been a substantial increase in investor participation, with delivery volume rising by 184.15% compared to the five-day average, indicating heightened interest in the stock.
In the broader market context, while Venmax has outperformed the Sensex in the short term, with a 10.80% gain over the past month compared to the benchmark's decline of 3.26%, it has underperformed over the past week. The Sensex has decreased by 0.77% during this period. The stock's liquidity appears adequate for trading, as it is based on 2% of the five-day average traded value. Overall, the combination of strong recent performance, increased investor interest, and favorable trading conditions contributes to the stock's rising price.